[Pneumocystis carinii pneumonia in HIV infections. Committee of the 1st Consensus Conference of anti-infectious therapy organized in May 1990 in Paris by the Société de Pathologie Infectieuse de Langue Française].
At the end of the first consensus conference on anti-infectious therapy organized by the French Language Society of Infectious Pathology in May 1990 and devoted to pneumocystosis in patients with human immunodeficiency virus (HIV) infection, the consensus committee produced this paper which answers the following 4 questions: what are the indications, technical requirements, sensitivity and benefits of induced expectoration in the diagnosis of Pneumocystis carinii pneumonia? what are the initial and secondary severity factors; in which cases is transfer to an intensive care unit indicated; in which manner can treatment be modified? what is the position occupied by corticosteroid therapy in the management of pneumocystosis? when is prophylaxis of pneumocystosis indicated; what prophylactic methods are used and how to choose among them?
D000163:Acquired Immunodeficiency Syndrome / Q000150:complications*; D000336:Aerosols; D002985:Clinical Protocols; D003622:Dapsone / Q000627:therapeutic use; D005602:France; D015658:HIV Infections / Q000150:complications*; D006801:Humans; D009894:Opportunistic Infections / Q000175:diagnosis / Q000517:prevention & control / Q000628:therapy; D010419:Pentamidine / Q000627:therapeutic use; D011020:Pneumonia, Pneumocystis / Q000175:diagnosis / Q000209:etiology* / Q000517:prevention & control / Q000628:therapy; D013183:Sputum / Q000469:parasitology; D015662:Trimethoprim, Sulfamethoxazole Drug Combination / Q000627:therapeutic use
D000336:Aerosols; D010419:Pentamidine; D015662:Trimethoprim, Sulfamethoxazole Drug Combination; D003622:Dapsone
La pneumocystose au cours de l'infection par le VIH. Comité du Consensus de la première conférence de consensus en thérapeutique anti-infectieuse organisée en mai 1990 à Paris par la Société de Pathologie Infectieuse de langue française.